CY1123348T1 - Μεθοδος για την παρασκευη ενισχυμενων πολυδυναμων βλαστοκυτταρων απο μεσεγχυματικα βλαστοκυτταρα με τη χρηση κλασματος φλοροταννινης - Google Patents
Μεθοδος για την παρασκευη ενισχυμενων πολυδυναμων βλαστοκυτταρων απο μεσεγχυματικα βλαστοκυτταρα με τη χρηση κλασματος φλοροταννινηςInfo
- Publication number
- CY1123348T1 CY1123348T1 CY20201100887T CY201100887T CY1123348T1 CY 1123348 T1 CY1123348 T1 CY 1123348T1 CY 20201100887 T CY20201100887 T CY 20201100887T CY 201100887 T CY201100887 T CY 201100887T CY 1123348 T1 CY1123348 T1 CY 1123348T1
- Authority
- CY
- Cyprus
- Prior art keywords
- stem cells
- enhanced
- pluripotent stem
- preparation
- fraction
- Prior art date
Links
- 210000002894 multi-fate stem cell Anatomy 0.000 title 1
- 210000000130 stem cell Anatomy 0.000 title 1
- 210000001778 pluripotent stem cell Anatomy 0.000 abstract 4
- 239000013028 medium composition Substances 0.000 abstract 2
- 241000031729 Dictyopteris prolifera Species 0.000 abstract 1
- 241000659328 Dictyota coriacea Species 0.000 abstract 1
- 241001512722 Ecklonia cava Species 0.000 abstract 1
- 241000631640 Ishige okamurae Species 0.000 abstract 1
- 241000199919 Phaeophyceae Species 0.000 abstract 1
- 241000195474 Sargassum Species 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000007348 cell dedifferentiation Effects 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229920001339 phlorotannin Polymers 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0668—Mesenchymal stem cells from other natural sources
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/76—Undefined extracts from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
- C12N2506/025—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells from extra-embryonic cells, e.g. trophoblast, placenta
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
- C12N2506/1392—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from mesenchymal stem cells from other natural sources
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Developmental Biology & Embryology (AREA)
- Transplantation (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Rheumatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Η παρούσα εφεύρεση αναφέρεται σε μια σύνθεση μέσου για την αποδιαφοροποίηση των ενισχυμένων παντοδύναμων βλαστοκυττάρων, η οποία περιέχει ένα κλάσμα φλοροταννίνης, το οποίο εκχυλίστηκε και απομονώθηκε από έναν τύπο καφέ φυκιών που επιλέχθηκε από την ομάδα που αποτελείται από τα Ecklonia cava, Dictyopteris prolifera, Dictyota coriacea, Sargassum homeri, Ishige okamurai και τα παρόμοια. Επιπλέον, η παρούσα εφεύρεση αναφέρεται σε μια μέθοδο για την παρασκευή ενισχυμένων παντοδύναμων βλαστοκυττάρων χρησιμοποιώντας τη σύνθεση μέσου. Τα ενισχυμένα παντοδύναμα βλαστοκύτταρα μπορούν να παρασκευαστούν με ασφάλεια, εύκολα και αποτελεσματικά με τη χρήση μεσεγχυματικών βλαστοκυττάρων με τη χρήση της σύνθεσης μέσου της παρούσας εφεύρεσης, και τα παρασκευασμένα ενισχυμένα παντοδύναμα βλαστοκύτταρα μπορούν να διαφοροποιηθούν σε διάφορα κύτταρα και έτσι μπορούν να είναι χρήσιμα ως ένας κυτταρικός θεραπευτικός παράγοντας.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20140062526 | 2014-05-23 | ||
KR1020150071240A KR101699761B1 (ko) | 2014-05-23 | 2015-05-21 | 플로로탄닌 분획물을 이용한 중간엽 줄기세포로부터 유도만능 줄기세포를 제조하는 방법 |
PCT/KR2015/005183 WO2015178728A1 (ko) | 2014-05-23 | 2015-05-22 | 플로로탄닌 분획물을 이용한 중간엽 줄기세포로부터 유도만능 줄기세포를 제조하는 방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1123348T1 true CY1123348T1 (el) | 2021-12-31 |
Family
ID=54883407
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20201100887T CY1123348T1 (el) | 2014-05-23 | 2020-09-21 | Μεθοδος για την παρασκευη ενισχυμενων πολυδυναμων βλαστοκυτταρων απο μεσεγχυματικα βλαστοκυτταρα με τη χρηση κλασματος φλοροταννινης |
Country Status (23)
Country | Link |
---|---|
US (1) | US10131881B2 (el) |
EP (1) | EP3147352B1 (el) |
JP (1) | JP6839982B2 (el) |
KR (1) | KR101699761B1 (el) |
CN (1) | CN105960452B (el) |
AU (1) | AU2015262123B2 (el) |
CA (1) | CA2949949C (el) |
CY (1) | CY1123348T1 (el) |
DK (1) | DK3147352T3 (el) |
ES (1) | ES2820577T3 (el) |
HR (1) | HRP20201525T1 (el) |
HU (1) | HUE050877T2 (el) |
IL (1) | IL249170A0 (el) |
LT (1) | LT3147352T (el) |
MX (1) | MX2016015357A (el) |
MY (1) | MY179152A (el) |
PH (1) | PH12016502330A1 (el) |
PL (1) | PL3147352T3 (el) |
PT (1) | PT3147352T (el) |
RS (1) | RS60817B1 (el) |
RU (1) | RU2668803C2 (el) |
SG (1) | SG11201609804RA (el) |
SI (1) | SI3147352T1 (el) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6700175B2 (ja) | 2013-11-01 | 2020-05-27 | ビービーエイチシー・カンパニー・リミテッドBbhc Co., Ltd. | 間葉系幹細胞から誘導多能性幹細胞を製造する方法及びその方法によって製造された誘導多能性幹細胞 |
KR101966315B1 (ko) * | 2017-04-26 | 2019-04-08 | 제주대학교 산학협력단 | 감태 추출물과 괭생이모자반 추출물을 이용한 면역억제용 조성물 |
CN113194743A (zh) * | 2018-12-05 | 2021-07-30 | 博塔医疗株式会社 | 包含褐藻多酚作为有效成分的用于改善食物香味的组合物 |
WO2021145742A1 (ko) * | 2020-01-17 | 2021-07-22 | 주식회사 만나스 | 플로로탄닌을 유효성분으로 포함하는 운동 기능 개선용 조성물 |
CN111557869A (zh) * | 2020-06-19 | 2020-08-21 | 湖北楚天香妆生物科技有限公司 | 昆布提取物的应用 |
CN114438037B (zh) * | 2022-01-25 | 2024-06-04 | 深圳市乐土生物医药有限公司 | 一种制备诱导性间充质干细胞的方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5818874A (ja) * | 1981-07-28 | 1983-02-03 | Shin Kobe Electric Mach Co Ltd | 鉛蓄電池の製造法 |
JP2932660B2 (ja) | 1990-10-09 | 1999-08-09 | 松下電器産業株式会社 | スクリーン印刷用スキージ装置 |
JP4146146B2 (ja) | 2002-03-25 | 2008-09-03 | 熊本県 | フロロタンニン類を主成分とする抗菌剤 |
US7910755B2 (en) * | 2004-09-29 | 2011-03-22 | Harbor Biosciences, Inc. | Stem cell expansion and uses |
BRPI0716762A2 (pt) * | 2006-09-13 | 2013-09-24 | Abbott Lab | melhorias da cultura celular |
WO2009157610A1 (en) * | 2008-06-26 | 2009-12-30 | Pusan National University Industry-University Cooperation Foundation | Selenium dedifferentiated cell, preparation method and usage thereof |
JP2010030917A (ja) * | 2008-07-25 | 2010-02-12 | Guraiko Materials:Kk | 肝炎予防剤又は肝炎治療剤 |
KR101166257B1 (ko) * | 2009-06-16 | 2012-07-19 | 한국생명공학연구원 | 미분화 다능성줄기세포의 제작, 유지 및 증식을 위한 뉴로펩타이드 y를 포함하는 배지 조성물 및 이를 이용한 다능성줄기세포의 배양 방법 |
CN103210082A (zh) * | 2010-09-15 | 2013-07-17 | 雷蒙特亚特特拉维夫大学有限公司 | 扩增胰岛β细胞和使其再分化的方法 |
KR101807704B1 (ko) * | 2011-04-12 | 2017-12-13 | 차의과학대학교 산학협력단 | 역분화-증진제를 이용한 역분화 만능 줄기세포의 제조방법 |
US20150072416A1 (en) * | 2012-05-29 | 2015-03-12 | Korea Research Institute Of Bioscience And Biotech | Metabolite for improving production, maintenance and proliferation of pluripotent stem cells, composition comprising the same, and method of culturing pluripotent stem cell using the same |
KR101542849B1 (ko) * | 2013-11-01 | 2015-08-10 | 주식회사 비비에이치씨 | 중간엽 줄기세포로부터 유도된 만능 줄기세포를 이용하여 간세포로 분화시키는 방법 |
KR101544195B1 (ko) * | 2013-11-01 | 2015-08-12 | 주식회사 비비에이치씨 | 중간엽 줄기세포로부터 유도만능 줄기세포를 제조하는 방법 및 그 방법에 의해 제조된 유도만능 줄기세포 |
KR101542850B1 (ko) * | 2013-11-01 | 2015-08-10 | 주식회사 비비에이치씨 | 중간엽 줄기세포로부터 유도된 만능 줄기세포를 이용하여 지방세포로 분화시키는 방법 |
KR101542847B1 (ko) * | 2013-11-01 | 2015-08-10 | 주식회사 비비에이치씨 | 중간엽 줄기세포로부터 유도된 만능 줄기세포를 이용하여 신경세포로 분화시키는 방법 |
KR101542846B1 (ko) * | 2013-11-01 | 2015-08-10 | 주식회사 비비에이치씨 | 중간엽 줄기세포로부터 유도된 만능 줄기세포를 이용하여 연골세포로 분화시키는 방법 |
KR101542848B1 (ko) * | 2013-11-01 | 2015-08-10 | 주식회사 비비에이치씨 | 중간엽 줄기세포로부터 유도된 만능 줄기세포를 이용하여 골아세포로 분화시키는 방법 |
-
2015
- 2015-05-21 KR KR1020150071240A patent/KR101699761B1/ko active IP Right Grant
- 2015-05-22 RS RS20201114A patent/RS60817B1/sr unknown
- 2015-05-22 HU HUE15795825A patent/HUE050877T2/hu unknown
- 2015-05-22 SG SG11201609804RA patent/SG11201609804RA/en unknown
- 2015-05-22 MX MX2016015357A patent/MX2016015357A/es unknown
- 2015-05-22 AU AU2015262123A patent/AU2015262123B2/en active Active
- 2015-05-22 PT PT157958257T patent/PT3147352T/pt unknown
- 2015-05-22 JP JP2016548353A patent/JP6839982B2/ja active Active
- 2015-05-22 SI SI201531351T patent/SI3147352T1/sl unknown
- 2015-05-22 ES ES15795825T patent/ES2820577T3/es active Active
- 2015-05-22 DK DK15795825.7T patent/DK3147352T3/da active
- 2015-05-22 CA CA2949949A patent/CA2949949C/en active Active
- 2015-05-22 RU RU2016150687A patent/RU2668803C2/ru active
- 2015-05-22 CN CN201580007099.0A patent/CN105960452B/zh active Active
- 2015-05-22 US US15/116,210 patent/US10131881B2/en active Active
- 2015-05-22 MY MYPI2016704340A patent/MY179152A/en unknown
- 2015-05-22 PL PL15795825T patent/PL3147352T3/pl unknown
- 2015-05-22 EP EP15795825.7A patent/EP3147352B1/en active Active
- 2015-05-22 LT LTEP15795825.7T patent/LT3147352T/lt unknown
-
2016
- 2016-11-23 IL IL249170A patent/IL249170A0/en active IP Right Grant
- 2016-11-23 PH PH12016502330A patent/PH12016502330A1/en unknown
-
2020
- 2020-09-21 CY CY20201100887T patent/CY1123348T1/el unknown
- 2020-09-23 HR HRP20201525TT patent/HRP20201525T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
LT3147352T (lt) | 2020-12-10 |
PT3147352T (pt) | 2020-09-29 |
CA2949949A1 (en) | 2015-11-26 |
RU2668803C2 (ru) | 2018-10-02 |
ES2820577T3 (es) | 2021-04-21 |
US10131881B2 (en) | 2018-11-20 |
HUE050877T2 (hu) | 2021-01-28 |
EP3147352A4 (en) | 2018-01-24 |
KR101699761B1 (ko) | 2017-01-25 |
DK3147352T3 (da) | 2020-09-28 |
US20170107481A1 (en) | 2017-04-20 |
EP3147352A1 (en) | 2017-03-29 |
AU2015262123B2 (en) | 2018-04-19 |
JP2017516455A (ja) | 2017-06-22 |
JP6839982B2 (ja) | 2021-03-10 |
MX2016015357A (es) | 2017-06-20 |
RS60817B1 (sr) | 2020-10-30 |
AU2015262123A1 (en) | 2016-08-25 |
PH12016502330B1 (en) | 2017-02-06 |
CN105960452A (zh) | 2016-09-21 |
SI3147352T1 (sl) | 2021-01-29 |
PH12016502330A1 (en) | 2017-02-06 |
IL249170A0 (en) | 2017-01-31 |
CN105960452B (zh) | 2019-11-22 |
RU2016150687A3 (el) | 2018-06-25 |
SG11201609804RA (en) | 2016-12-29 |
CA2949949C (en) | 2023-03-28 |
EP3147352B1 (en) | 2020-08-12 |
PL3147352T3 (pl) | 2021-01-25 |
RU2016150687A (ru) | 2018-06-25 |
MY179152A (en) | 2020-10-29 |
KR20150135136A (ko) | 2015-12-02 |
HRP20201525T1 (hr) | 2021-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1123348T1 (el) | Μεθοδος για την παρασκευη ενισχυμενων πολυδυναμων βλαστοκυτταρων απο μεσεγχυματικα βλαστοκυτταρα με τη χρηση κλασματος φλοροταννινης | |
CY1122791T1 (el) | Μεθοδος για τη διαφοροποιηση του πλειοδυναμου βλαστικου κυτταρου επαγομενη απο το μεσεγχυματικο βλαστικο κυτταρο σε ηπατοκυτταρο | |
IL312867A (en) | Autologous T cells used to treat B-cell malignancies and other types of cancer and preparations thereof | |
CY1122275T1 (el) | Μεσεγχυματικα στρωματικα κυτταρα και χρησεις που σχετιζονται με αυτα | |
EA201891212A1 (ru) | Адресная дезорганизация клеточного рецептора гкгс | |
CY1122954T1 (el) | Μεθοδος για τη διαφοροποιηση του πλειοδυναμου βλαστικου κυτταρου επαγομενη απο το μεσεγχυματικο βλαστικο κυτταρο σε νευρωνα | |
CY1122798T1 (el) | Μεθοδος για τη διαφοροποιηση του πλειοδυναμου βλαστικου κυτταρου επαγομενη απο το μεσεγχυματικο βλαστικο κυτταρο σε χονδροκυτταρο | |
MX2018001531A (es) | Medio de cultivo celular complementado con taurina y metodos de uso. | |
MX2019000643A (es) | Receptores de antigenos quimericos y metodos de uso. | |
AR101845A1 (es) | Anticuerpos anti-her2 e inmunoconjugados | |
MX2017004890A (es) | Metodos y composiciones para la generación o el mantenimiento de células pluripotentes. | |
BR112017014218A2 (pt) | método para a oxidação eletroquímica, célula eletroquímica, método para a oxidação fotoeletroquímica e célula fotoeletroquímica | |
BR112013002811A8 (pt) | meios básicos simplificados para cultura celular pluripotente de humano | |
EA201391523A1 (ru) | Композиции и способы для переноса энергии митохондрий аутологичных герминативных клеток | |
EA201590488A1 (ru) | Способы модификации клеток-хозяев | |
SG10201807292YA (en) | Improved reprogramming methods and cell culture platforms | |
EP3070163A4 (en) | Method for preparing induced pluripotent stem cell, composition used in method, and uses thereof | |
GB2548740A (en) | Methods for generation of podocytes from pluripotent stem cells and cells produced by the same | |
EP3369810A4 (en) | METHOD FOR PRODUCING CELL POPULATION WITH MESENCHYMAL STEM CELLS, MESENCHYMAL STEM CELLS, CELL POPULATION AND PHARMACEUTICAL COMPOSITION | |
AR093446A1 (es) | Anticuerpos de antihemaglutinina y metodos de uso | |
EP3489351A4 (en) | CELL CULTIVATION METHOD, SUSPENDED CELL ELIMINATION METHOD AND METHOD FOR KILLING SUSPENDED CELLS | |
IL261623A (en) | Stem cells expressing mesenchymal and neuronal markers, compositions containing them and methods for their preparation | |
CY1123144T1 (el) | Επαγωγη καρδιακης αναγεννησης μe microrna | |
CY1122842T1 (el) | Μεθοδος για τη διαφοροποιηση του πλειοδυναμου βλαστικου κυτταρου επαγομενη απο το μεσεγχυματικο βλαστικο κυτταρο σε οστεοβλαστες | |
MX2016013631A (es) | Celulas huespedes modificadas y usos de las mismas. |